Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Xilio Therapeutics Inc XLO

Healthcare Biotechnology
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The Company is using its proprietary platform to advance a pipeline of novel, tumor-activated... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:XLO)

Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Advanced Solid Tumors

GlobeNewswire 7 days ago

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results

GlobeNewswire 7 days ago

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire October 30, 2024

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire October 4, 2024

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 2, 2024

Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire August 28, 2024

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

GlobeNewswire June 13, 2024

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results

GlobeNewswire May 14, 2024
View More News ››

Opinion & Analysis (NDAQ:XLO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:XLO)

Xilio Therapeutics, Inc. (XLO): A Promising Biotech Tackling

http://beyondspx.com/2024/08/02/xilio-therapeutics-inc-xlo-a-promising-biotech-tackling-cancer-with-innovative-tumor-activated-therapies/
MikeTester - August 3, 2024

Xilio Therapeutics to Present at Guggenheim 6th Annual Biote

News; $XLO Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology ConferenceWALTHAM, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE)...
whytestocks - January 31, 2024
View more Bullboard ››

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc. is a Canada-based junior exploration company. It is engaged in the exploration and evaluation ...
View More »